These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2696694)

  • 1. Targeted plasma drug concentration: a new therapeutic approach to relapsed nonlymphoblastic leukemia in children.
    Mirro J; Crom WR; Kalwinsky DK; Santana VM; Baker DK; Belt J
    Haematol Blood Transfus; 1989; 32():82-7. PubMed ID: 2696694
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy of childhood acute nonlymphocytic leukemia: the Pediatric Oncology Group experience (1977-1988).
    Steuber CP; Culbert SJ; Ravindranath Y; Krischer J; Ragab A; Civin C; Inoue S; Ruymann F; Leventhal B; Wilkinson R
    Haematol Blood Transfus; 1990; 33():198-209. PubMed ID: 2182412
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary results of intensive therapy of children and adolescents with acute nonlymphocytic leukemia--a Childrens Cancer Study Group report.
    Lampkin BC; Woods WG; Buckley JD; Hammond GD
    Haematol Blood Transfus; 1990; 33():210-4. PubMed ID: 1691130
    [No Abstract]   [Full Text] [Related]  

  • 4. Second long-term remission achieved with low-dose Ara-C in children with relapsed acute nonlymphoblastic leukemia.
    Miniero R; Saracco P; Cordero di Montezemolo L; Fiandino G; Comelli A; Madon E
    Pediatr Hematol Oncol; 1987; 4(3):273-6. PubMed ID: 3152932
    [No Abstract]   [Full Text] [Related]  

  • 5. Gemtuzumab Ozogamicin Containing Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia (AML) in Children.
    Liu AP; Leung AW; Cheuk DK; Lee V; Ha SY
    J Pediatr Hematol Oncol; 2018 Mar; 40(2):163-168. PubMed ID: 29240026
    [No Abstract]   [Full Text] [Related]  

  • 6. [ACMP two-step therapy for children with acute nonlymphoblastic leukemia].
    Kigasawa H; Nishihira H; Iizuka A; Nagao T
    Rinsho Ketsueki; 1985 Jan; 26(1):36-41. PubMed ID: 3858558
    [No Abstract]   [Full Text] [Related]  

  • 7. Family History and Relapse in Pediatric Acute Myeloid Leukemia.
    Mehrvar A; Tashvighi M; Faranoush M; Reinhardt D; Niktoreh Mofrad N; Hedayati Asl AA; Alebouyeh M
    Pediatr Blood Cancer; 2015 Dec; 62(12):2235-7. PubMed ID: 26184891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of busulfan, cyclophosphamide and etoposide followed by autologous transplantation for acute myeloid leukemia in remission.
    Bilgrami S; Edwards RL; Bona RD; Kazierad D; Furlong F; Fox J; Clive J; Naqvi BH; Tutschka PJ
    Acta Haematol; 2000; 104(2-3):144-7. PubMed ID: 11154994
    [No Abstract]   [Full Text] [Related]  

  • 9. The results of treatment with idarubicin in childhood acute nonlymphoblastic leukemia.
    Saşmaz I; Tanyeli A; Bayram I; Antmen B; Yilmaz L; Küçükosmanoğlu O; Kilinç Y
    Turk J Pediatr; 2004; 46(1):32-7. PubMed ID: 15074372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.
    Liu L; Qu Q; Jiao W; Zhang Y; Li X; Ding C; Wu D
    Leuk Res; 2015 Aug; 39(8):805-11. PubMed ID: 26021434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FLAG (fludarabine, high-dose cytarabine, and G-CSF) for refractory and high-risk relapsed acute leukemia in children.
    McCarthy AJ; Pitcher LA; Hann IM; Oakhill A
    Med Pediatr Oncol; 1999 Jun; 32(6):411-5. PubMed ID: 10358698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testicular relapse in children with acute nonlymphoblastic leukemia.
    Furman WL; Fontanesi J; Hustu O; Dahl GV; Kalwinsky DK; Pui CH
    Cancer; 1990 Nov; 66(10):2095-8. PubMed ID: 2224763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The first Russian trial of treating patients with acute nonlymphoblastic leukemias with novantrone combined with cytosar].
    Volkova MA; Kaletin GI
    Ter Arkh; 1992; 64(7):18-21. PubMed ID: 1440359
    [No Abstract]   [Full Text] [Related]  

  • 14. Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate.
    Abrahamsson J; Forestier E; Heldrup J; Jahnukainen K; Jónsson OG; Lausen B; Palle J; Zeller B; Hasle H
    J Clin Oncol; 2011 Jan; 29(3):310-5. PubMed ID: 21149663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute lymphoblastic leukemia: clinical data and results of intensive chemotherapy].
    Ruiz Soler JG; Fernández Navarro JM; Verdeguer Miralles A; Esquembre Menor C; Ferris Tortajada J; Castel Sánchez V
    An Esp Pediatr; 1990 Jan; 32(1):58-62. PubMed ID: 2327666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
    Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
    J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular response in two children with relapsed acute myeloid leukemia treated with a combination of gemtuzumab ozogamicin and cytarabine.
    Brethon B; Auvrignon A; Cayuela JM; Lapillonne H; Leverger G; Baruchel A
    Haematologica; 2006 Mar; 91(3):419-21. PubMed ID: 16531270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study.
    Cooper TM; Cassar J; Eckroth E; Malvar J; Sposto R; Gaynon P; Chang BH; Gore L; August K; Pollard JA; DuBois SG; Silverman LB; Oesterheld J; Gammon G; Magoon D; Annesley C; Brown PA
    Clin Cancer Res; 2016 Aug; 22(16):4014-22. PubMed ID: 26920889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study.
    van Eijkelenburg NKA; Rasche M; Ghazaly E; Dworzak MN; Klingebiel T; Rossig C; Leverger G; Stary J; De Bont ESJM; Chitu DA; Bertrand Y; Brethon B; Strahm B; van der Sluis IM; Kaspers GJL; Reinhardt D; Zwaan CM
    Haematologica; 2018 Sep; 103(9):1484-1492. PubMed ID: 29773602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myelogenous leukemia: current status of therapy in children.
    Ritter J; Creutzig U; Riehm HJ; Schellong G
    Recent Results Cancer Res; 1984; 93():204-15. PubMed ID: 6382480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.